Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06704958 · ClinicalTrials.gov registry record · NA
Augmented Momentary Personal Ecological Risk Evaluation
A NA study of Suicidal Ideation and Self Harm, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06704958: Recruiting NA study of Suicidal Ideation and Self Harm, sponsored by University of Washington.
NCT06704958 is a NA study of Suicidal Ideation and Self Harm that is actively recruiting participants, run by University of Washington. The registered enrollment target is 50 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06704958, a NA study of Suicidal Ideation and Self Harm, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this intervention study is to co-design and test an Ecological Momentary Assessment (EMA) prototype tool with young adults aged 16-30 experiencing suicidality to see if it is an acceptable and usable clinical tool for risk management. The main study aims are: * To co-design a prototype EMA suicide risk monitoring system with patients and health care provider input using Human Centered Design (HCD) methods. * To test the developed EMA protype with providers and their young adult patients aged 16-30 experiencing suicidality to determine if the EMA prototype is an acceptable and usable clinical tool. Young adult participants receiving care for active suicidal ideation will * Download and use the EMA prototype for a total of two months. * Complete 3 online surveys at 0, 1 and 2 months after enrolled in the study.
Primary Outcome
This is a four-item measure of intervention acceptability, where each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable. Total mean scores range from 1 - 5, with higher scores indicating higher acceptability. Participants will complete this measure after 4 weeks of using the mobile mental health app to which they are randomized.
Conditions Studied
Interventions
- OTHER AMPERE EMA app
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-09-25 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What NCT06704958 shows while recruiting
NCT06704958 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which AMPERE EMA app is the first listed.
NCT06704958 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06704958 about?
NCT06704958 is a clinical study titled "Augmented Momentary Personal Ecological Risk Evaluation". The goal of this intervention study is to co-design and test an Ecological Momentary Assessment (EMA) prototype tool with young adults aged 16-30 experiencing suicidality to see if it is an acceptable and usable clinical tool for risk management. The main study aims are: * To co-design a prototype...
What is the current status of trial NCT06704958?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-25. Estimated completion is 2026-07-01.
What conditions does trial NCT06704958 study?
This clinical trial studies the following conditions: Suicidal Ideation, Self Harm.
What interventions are being tested in trial NCT06704958?
The interventions under investigation include: AMPERE EMA app (OTHER).
Who is sponsoring clinical trial NCT06704958?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06704958 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06704958's enrollment target sits among peer trials
50 67th of 84 higher than 16 of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI